AU2702795A - Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration - Google Patents
Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administrationInfo
- Publication number
- AU2702795A AU2702795A AU27027/95A AU2702795A AU2702795A AU 2702795 A AU2702795 A AU 2702795A AU 27027/95 A AU27027/95 A AU 27027/95A AU 2702795 A AU2702795 A AU 2702795A AU 2702795 A AU2702795 A AU 2702795A
- Authority
- AU
- Australia
- Prior art keywords
- solid
- nicotine
- xanthine
- caffeine
- semi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26466694A | 1994-06-23 | 1994-06-23 | |
US264666 | 1994-06-23 | ||
PCT/US1995/007380 WO1996000069A1 (en) | 1994-06-23 | 1995-06-09 | Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2702795A true AU2702795A (en) | 1996-01-19 |
Family
ID=23007084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27027/95A Abandoned AU2702795A (en) | 1994-06-23 | 1995-06-09 | Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU2702795A (en) |
IL (1) | IL114130A0 (en) |
MA (1) | MA23586A1 (en) |
PE (1) | PE39996A1 (en) |
WO (1) | WO1996000069A1 (en) |
ZA (1) | ZA955033B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2340397A (en) * | 1996-03-21 | 1997-10-10 | Mayo Foundation For Medical Education And Research | Use of nicotine to treat liver disease |
AUPO108596A0 (en) * | 1996-07-18 | 1996-08-08 | Collier, Gregory | Treatment of obesity |
CA2325106A1 (en) * | 1999-12-06 | 2001-06-06 | Stanley L. Gore | Compositions and methods for intranasal delivery of active agents to the brain |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
CA2526475A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778677A (en) * | 1981-07-09 | 1988-10-18 | Ebbesen Gerald K | Method for treatment of nicotine craving |
US4568676A (en) * | 1983-11-25 | 1986-02-04 | Thomas Jefferson University | Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor |
DE3506406A1 (en) * | 1985-02-23 | 1986-08-28 | Hans-Josef 5600 Wuppertal Stromberg | DEVICE FOR THE DEWNING OF EATING, DRINKING, SMOKING AND / OR ADDICTIVE Habits |
US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
US4959380A (en) * | 1988-12-19 | 1990-09-25 | Wilson Jordan E | Method of treating people to stop smoking and composition |
US5051426A (en) * | 1990-03-27 | 1991-09-24 | Parnell Pharmaceuticals, Inc. | Method for effecting withdrawal from drug dependency |
-
1995
- 1995-06-09 AU AU27027/95A patent/AU2702795A/en not_active Abandoned
- 1995-06-09 WO PCT/US1995/007380 patent/WO1996000069A1/en active Application Filing
- 1995-06-13 IL IL11413095A patent/IL114130A0/en unknown
- 1995-06-16 MA MA23929A patent/MA23586A1/en unknown
- 1995-06-19 ZA ZA955033A patent/ZA955033B/en unknown
- 1995-06-22 PE PE1995272089A patent/PE39996A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL114130A0 (en) | 1995-10-31 |
WO1996000069A1 (en) | 1996-01-04 |
ZA955033B (en) | 1996-02-15 |
MA23586A1 (en) | 1995-12-31 |
PE39996A1 (en) | 1996-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2703795A (en) | Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine | |
CA2127253A1 (en) | Composition to help stop smoking | |
AU2770895A (en) | Treatment of nicotine craving and/or smoking withdrawal symptoms with an oral composition containing nicotine and caffeine or xanthine | |
EP0296236A4 (en) | Nasal delivery of caffeine. | |
CA2146954A1 (en) | Breath activated nicotine inhalers | |
WO2000016762A3 (en) | Method for reducing nicotine dependency | |
HUT68640A (en) | Nicotine inhalaling instrument and method of fabricating the same | |
GB9312853D0 (en) | Chemical compounds | |
EP0824927A3 (en) | Smoke cessation aid | |
NO963322L (en) | Procedure for the treatment of abstinence in substance abuse | |
AU2703695A (en) | Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine | |
AU2702795A (en) | Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration | |
EP1078637A3 (en) | Composition for the treatment and prevention of nicotine addiction containing a nicotine receptor agonist and an anti-depressant or anti-anxiety drug | |
GB2219587B (en) | Nitrogen-containing derivatives of carboxymethylcellulose,their preparation and their luse in cosmetic formulations | |
EP0745380A3 (en) | Tobacco substitute | |
WO1996005836A3 (en) | Methods of treating cold symptoms using pentoxifylline | |
AU4476089A (en) | Use of azepinone derivatives for the treatment of respiratory tract disorders | |
WO1996036324A3 (en) | Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions | |
Sherwood et al. | No differences in the psychomotor response of heavy, light and non-smokers to the acute administration of nicotine. | |
AU8096094A (en) | Use of nicotine substitutes for the treatment of nicotine withdrawal | |
NO943293L (en) | Use of a drug in the treatment of smoking | |
AU2446895A (en) | Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers | |
GB9410482D0 (en) | Tobacco smokers' mouthpiece | |
AU2100188A (en) | Nicotine level reduction in cigarettes | |
Sherwood et al. | The use of nicotine gum in psychopharmacological research. |